JANX Stock Summary and Trading Ideas (Janux Therapeutics | NASDAQ:JANX)

Janux Therapeutics Inc is a clinical-stage biopharmaceutical company developing tumor-activated immunotherapies for cancer. The proprietary technology of the company has enabled the development of distinct bispecific platforms: Tumor Activated T Cell Engagers (TRACTr), Tumor Activated Immunomodulators (TRACIr), and Adaptive Immune Response Modulator (ARM) platforms. The TRACTr platform produces T cell engagers (TCEs) with a tumor antigen-binding domain and a CD3 T cell binding domain, while the TRACIr platform produces bispecifics with a tumor antigen-binding domain and a costimulatory CD28 binding domain.

Janux Therapeutics trades on the NASDAQ stock market under the symbol JANX.

As of July 31, 2026, JANX stock price declined to $15.17 with 476,559 million shares trading.

JANX has a beta of 1.27, meaning it tends to be more sensitive to market movements. JANX has a correlation of 0.03 to the broad based SPY ETF.

JANX has a market cap of $924.79 million. This is considered a Small Cap stock.

Last quarter Janux Therapeutics reported $4 million in Revenue and -$.39 earnings per share. This fell short of revenue expectation by $-3 million and exceeded earnings estimates by $.13.

In the last 3 years, JANX traded as high as $71.71 and as low as $5.65.

The top ETF exchange traded funds that JANX belongs to (by Net Assets): XBI, VTI, IWM, VXF, IBB.

JANX has underperformed the market in the last year with a price return of -36.8% while the SPY ETF gained +19.4%. However, in the short term, JANX had mixed performance relative to the market. It has outperformed in the last 3 months, returning +5.6% vs +4.2% return in SPY. But in the last 2 weeks, JANX shares have been beat by the market, returning -6.7% compared to an SPY return of +0.5%.

JANX support price is $15.11 and resistance is $16.05 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that JANX shares will trade within this expected range on the day.